(Reuters) – On Thursday, a French Appeal Court ruled that Bayer AG's Monsanto business was responsible for the health problems of a farmer who had inhaled a weed killer product.
The provision to farmer Paul Francois was announced in a statement by a plaintiff group. A Bayer spokeswoman in France also confirmed the ruling.
"We note the decision to Francois and study the complete ruling," said the spokesman.
Mr. Francois, who says he was suffering from neurological problems after being inhaled in Lasso weedkiller in 2004, accused Monsanto of not providing adequate safety warnings.
For a decade long legal battle Francois won judgments against Monsanto in 201
The latest court on Thursday, however, did not establish compensation for the farmer.
The court of appeal referred the case to another court in the southeastern city of Lyon, the plantiff "Phyto-victimes" said. The group represents workers who claim health problems due to exposure to pesticides.
The court in the French case comes as Monsanto faces court trials in the United States on alleged cancer connections to its glyphosate-based weed killers.
Lasso was banned in France in 2007 after the product had already been withdrawn in some other countries.
It used another active substance for glyphosate, the chemical in Monsanto's best-selling weedkiller Roundup and the target of trials in the United States.
The legal problems surrounding glyphosate have contributed to Bayer losing approximately EUR 30 billion ($ 33.83 billion) from its market value since August. The German Group's CEO said on Thursday that it was "massively affected" by the disputes.